PATENT CLAIM ANALYSIS

Application Number: 15760660
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["424", "130100"]

Abstract:
Methods of diagnosis and methods of treatment and prevention for autism spectrum disorder are provided using decoy antigens to maternal brain-reactive antibodies.

Claim (Index 22):
A method of determining the likelihood that a fetus or infant of a pregnant prospective mother will present with an autism spectrum disorder comprising quantifying the levels of antibodies directed to one or more of Caspr2, KCNAB2, KCNAB1, EDIL3, IVD, SULT4A1, TNIP2, RAI16 or GDP D5 in a sample obtained from the mother's blood and comparing each quantified level to a predetermined control level for that respective antibody, wherein an increased titer of antibody or antibodies for one or more of Caspr2, KCNAB2, KCNAB1, EDIL3, IVD, SULT4A1, TNIP2, RAI16 or GDP D5 indicates an increased likelihood of the fetus or infant of a pregnant prospective mother will present with an autism spectrum disorder.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.09524
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15042976', '12266814', '11381943', '15353037', '15136021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7064316365643982
- 35 USC 102 Novelty (BERT): 0.4855542179416204
- Combined Prediction Score: 0.6843438947021204
- Mean Citation Score: 172.780086
- Max Citation Score: 210.8995
- Similarity Product: 157.35761208778618

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test